What is the address of DR. TIJDHOF PRISKA, GYNAECOLOGIE?

The registered office of DR. TIJDHOF PRISKA, GYNAECOLOGIE is located at Arboretumlaan 4, 3080 Tervuren.

Is DR. TIJDHOF PRISKA, GYNAECOLOGIE still active?

Yes. According to the CBE (18 September 2026) DR. TIJDHOF PRISKA, GYNAECOLOGIE is active, legal situation “Normale toestand”, started on 17 April 2012.

Is DR. TIJDHOF PRISKA, GYNAECOLOGIE registered on Peppol?

Yes, DR. TIJDHOF PRISKA, GYNAECOLOGIE is registered on the Peppol network with ID 0208:0845303233.

What is the enterprise number of DR. TIJDHOF PRISKA, GYNAECOLOGIE?

The enterprise number of DR. TIJDHOF PRISKA, GYNAECOLOGIE is BE0845303233.

When was DR. TIJDHOF PRISKA, GYNAECOLOGIE founded?

DR. TIJDHOF PRISKA, GYNAECOLOGIE was founded on 17 April 2012.

Who are the directors of DR. TIJDHOF PRISKA, GYNAECOLOGIE?

According to the 2025 annual accounts, the directors of DR. TIJDHOF PRISKA, GYNAECOLOGIE are: Priska Tijdhof.

Is DR. TIJDHOF PRISKA, GYNAECOLOGIE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 17 April 2012; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. TIJDHOF PRISKA, GYNAECOLOGIE make in 2025?

DR. TIJDHOF PRISKA, GYNAECOLOGIE posted a profit after taxes of € 81,236 in financial year 2025.

What is the revenue of DR. TIJDHOF PRISKA, GYNAECOLOGIE?

As a small company, DR. TIJDHOF PRISKA, GYNAECOLOGIE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 116,391.

DR. TIJDHOF PRISKA, GYNAECOLOGIE (Private Limited)

Dossier DR. TIJDHOF PRISKA, GYNAECOLOGIE, printed on 18 September 2026 from databakkes.be/en/0845303233/dr-tijdhof-priska-gynaecologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. TIJDHOF PRISKA, GYNAECOLOGIE from Tervuren, company number BE0845303233, closed financial year 2025 with a result of € 81,236 after tax. For that financial year DR. TIJDHOF PRISKA, GYNAECOLOGIE recorded a gross margin of € 116,391 and equity of € 438,726. Compared with financial year 2024, the result moved from € 67,425 to € 81,236. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on January 12, 2026.

What it is worth Growing

€ 438,726

▲ 23% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 81,236

▲ 20% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 175,600

▼ 8% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 426,326.

People and assets in 2025

Vehicles and equipment

€ 4,371

▲ 249% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 2,333

▲ € 2,144 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 16,601

▼ 22% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 93,969 Gross margin 2022: € 93,969 First fiscal year in the series	€ 86,783 Gross margin 2023: € 86,783 ▼ 8% vs 2022 (€ 93,969) Unfavourable step	€ 99,709 Gross margin 2024: € 99,709 ▲ 15% vs 2023 (€ 86,783) Favourable step	€ 116,391 Gross margin 2025: € 116,391 ▲ 17% vs 2024 (€ 99,709) Favourable step	▲ 17%
Profit after taxes	€ 57,997 Profit after taxes 2022: € 57,997 First fiscal year in the series	€ 58,813 Profit after taxes 2023: € 58,813 ▲ 1% vs 2022 (€ 57,997) Favourable step	€ 67,425 Profit after taxes 2024: € 67,425 ▲ 15% vs 2023 (€ 58,813) Favourable step	€ 81,236 Profit after taxes 2025: € 81,236 ▲ 20% vs 2024 (€ 67,425) Favourable step	▲ 20%
Equity	€ 279,858 Equity 2022: € 279,858 First fiscal year in the series	€ 319,826 Equity 2023: € 319,826 ▲ 14% vs 2022 (€ 279,858) Favourable step	€ 357,489 Equity 2024: € 357,489 ▲ 12% vs 2023 (€ 319,826) Favourable step	€ 438,726 Equity 2025: € 438,726 ▲ 23% vs 2024 (€ 357,489) Favourable step	▲ 23%
Total debts	€ 137,979 Total debts 2022: € 137,979 First fiscal year in the series	€ 40,616 Total debts 2023: € 40,616 ▼ 71% vs 2022 (€ 137,979) Favourable step	€ 67,804 Total debts 2024: € 67,804 ▲ 67% vs 2023 (€ 40,616) Unfavourable step	€ 18,934 Total debts 2025: € 18,934 ▼ 72% vs 2024 (€ 67,804) Favourable step	▼ 72%
Cash	€ 288,056 Cash 2022: € 288,056 First fiscal year in the series	€ 111,345 Cash 2023: € 111,345 ▼ 61% vs 2022 (€ 288,056) Unfavourable step	€ 190,322 Cash 2024: € 190,322 ▲ 71% vs 2023 (€ 111,345) Favourable step	€ 175,600 Cash 2025: € 175,600 ▼ 8% vs 2024 (€ 190,322) Unfavourable step	▼ 8%
Land & buildings	€ 14,674 Land & buildings 2022: € 14,674 First fiscal year in the series	€ 11,241 Land & buildings 2023: € 11,241 ▼ 23% vs 2022 (€ 14,674) Unchanged	€ 7,808 Land & buildings 2024: € 7,808 ▼ 31% vs 2023 (€ 11,241) Unchanged	€ 5,481 Land & buildings 2025: € 5,481 ▼ 30% vs 2024 (€ 7,808) Unchanged	▼ 30%
Retained profit	€ 267,458 Retained profit 2022: € 267,458 First fiscal year in the series	€ 307,426 Retained profit 2023: € 307,426 ▲ 15% vs 2022 (€ 267,458) Favourable step	€ 345,089 Retained profit 2024: € 345,089 ▲ 12% vs 2023 (€ 307,426) Favourable step	€ 426,326 Retained profit 2025: € 426,326 ▲ 24% vs 2024 (€ 345,089) Favourable step	▲ 24%
Dividend	€ 271,773 Dividend 2022: € 271,773 First fiscal year in the series	€ 18,845 Dividend 2023: € 18,845 ▼ 93% vs 2022 (€ 271,773) Unchanged	€ 29,762 Dividend 2024: € 29,762 ▲ 58% vs 2023 (€ 18,845) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 29,762) Unchanged	▼ 100%
Bank debt	€ 4,974 Bank debt 2022: € 4,974 First fiscal year in the series	€ 0 Bank debt 2023: € 0 ▼ 100% vs 2022 (€ 4,974) Favourable step	€ 0 Bank debt 2024: € 0 Unchanged (€ 0) Unchanged	€ 0 Bank debt 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 417,837 Balance sheet total 2022: € 417,837 First fiscal year in the series	€ 360,442 Balance sheet total 2023: € 360,442 ▼ 14% vs 2022 (€ 417,837) Unchanged	€ 425,294 Balance sheet total 2024: € 425,294 ▲ 18% vs 2023 (€ 360,442) Unchanged	€ 457,660 Balance sheet total 2025: € 457,660 ▲ 8% vs 2024 (€ 425,294) Unchanged	▲ 8%

Key figures of DR. TIJDHOF PRISKA, GYNAECOLOGIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.

What happened to DR. TIJDHOF PRISKA, GYNAECOLOGIE?

What happened at DR. TIJDHOF PRISKA, GYNAECOLOGIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jan 12, 2026 New annual accounts for financial year 2025: profit of € 81,236 (▲ 20% vs 2024). Source: NBB ↗
Apr 17, 2012 New establishment in Elsene. KBO
Apr 17, 2012 Start of the company according to the CBE. KBO
2012 Priska Tijdhof became a director. NBB

In short

From € 57,997 profit in 2022 to € 81,236 profit in 2025.

Paid € 107,697 in corporate taxes since 2022.

Best year ever: 2025, with € 81,236 profit.

Paid out € 320,380 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. TIJDHOF PRISKA, GYNAECOLOGIE? We notify you, reason included.

Follow DR. TIJDHOF PRISKA, GYNAECOLOGIE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Priska Tijdhof

DR. TIJDHOF PRISKA, GYNAECOLOGIE

Behind DR. TIJDHOF PRISKA, GYNAECOLOGIE is Priska Tijdhof.

See the full network in the app

Directors

According to the 2025 annual accounts

Priska Tijdhof

Director

since 2012

Establishments

Establishment units

Physical locations of this company

Registered office

Arboretumlaan 4

3080 Tervuren

2.208.891.423

Adolphe Mathieustraat 46

1050 Elsene

Active since 17 April 2012

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0845.303.233
VAT number: BE 0845.303.233
Registered office: Arboretumlaan 4, 3080 Tervuren
Names & denominations: DR. TIJDHOF PRISKA, GYNAECOLOGIE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 17 April 2012
Peppol: Active · Active since 27 Mar 2026

View on CBE Public ↗ Annual accounts (NBB) ↗